Chelsea Counsel Company’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.36K | Hold |
4,626
| – | – | ﹤0.01% | 182 |
|
|
2025
Q1 | $6.89K | Buy |
+4,626
| New | +$6.89K | ﹤0.01% | 177 |
|
|
2024
Q4 | – | Sell |
-11,252
| Closed | -$141K | – | 199 |
|
|
2024
Q3 | $141K | Buy |
11,252
+1,000
| +10% | +$12.5K | 0.07% | 108 |
|
|
2024
Q2 | $150K | Buy |
10,252
+7,000
| +215% | +$102K | 0.07% | 104 |
|
|
2024
Q1 | $73K | Hold |
3,252
| – | – | 0.04% | 105 |
|
|
2023
Q4 | $61.5K | Hold |
3,252
| – | – | 0.03% | 113 |
|
|
2023
Q3 | $55.6K | Hold |
3,252
| – | – | 0.03% | 122 |
|
|
2023
Q2 | $97.6K | Hold |
3,252
| – | – | 0.05% | 114 |
|
|
2023
Q1 | $95.1K | Buy |
+3,252
| New | +$95.1K | 0.05% | 114 |
|